Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Notes Payables (2020 - 2025)

Trulieve Cannabis has reported Notes Payables over the past 6 years, most recently at $4.1 million for Q4 2025.

  • Quarterly results put Notes Payables at $4.1 million for Q4 2025, down 96.52% from a year ago — trailing twelve months through Dec 2025 was $4.1 million (down 96.52% YoY), and the annual figure for FY2025 was $4.1 million, down 96.52%.
  • Notes Payables for Q4 2025 was $4.1 million at Trulieve Cannabis, up from $3.7 million in the prior quarter.
  • Over the last five years, Notes Payables for TCNNF hit a ceiling of $121.8 million in Q4 2023 and a floor of $2.0 million in Q1 2021.
  • Median Notes Payables over the past 5 years was $9.5 million (2022), compared with a mean of $44.3 million.
  • Biggest five-year swings in Notes Payables: soared 2035.85% in 2023 and later crashed 96.92% in 2025.
  • Trulieve Cannabis' Notes Payables stood at $10.1 million in 2021, then surged by 979.72% to $108.5 million in 2022, then rose by 12.18% to $121.8 million in 2023, then decreased by 3.84% to $117.1 million in 2024, then tumbled by 96.52% to $4.1 million in 2025.
  • The last three reported values for Notes Payables were $4.1 million (Q4 2025), $3.7 million (Q3 2025), and $3.7 million (Q2 2025) per Business Quant data.